Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid Arthritis


Cansu B. , Cansu D. U. , Kasifoglu T., Gulbas Z., Korkmaz C.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.17, no.1, pp.14-17, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.1097/rhu.0b013e318204a587
  • Title of Journal : JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
  • Page Numbers: pp.14-17

Abstract

Background: Adiponectin is an adipocyte-derived adipokine with immunosuppressive and anti-inflammatory properties. It also decreases expression of adhesion molecules. In terms of its relationship with acute-phase reactants, there are conflicting results in patients with rheumatoid arthritis (RA).